Clinical Trial Update: NMDA Modulation in Major Depressive Disorder in Late- Life [Phase 2]

View source ↗

Summary

Phase 2 trial update on NMDA modulation for major depressive disorder in late life has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED